CN103146645B - 诱导间充质干细胞成为软骨细胞的方法 - Google Patents
诱导间充质干细胞成为软骨细胞的方法 Download PDFInfo
- Publication number
- CN103146645B CN103146645B CN201310081154.3A CN201310081154A CN103146645B CN 103146645 B CN103146645 B CN 103146645B CN 201310081154 A CN201310081154 A CN 201310081154A CN 103146645 B CN103146645 B CN 103146645B
- Authority
- CN
- China
- Prior art keywords
- chondrocyte
- mscs
- stem cell
- mesenchymal stem
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000001612 chondrocyte Anatomy 0.000 title claims abstract description 179
- 230000001939 inductive effect Effects 0.000 title claims abstract description 61
- 238000000034 method Methods 0.000 title claims abstract description 56
- 210000002901 mesenchymal stem cell Anatomy 0.000 title claims abstract description 35
- 230000004069 differentiation Effects 0.000 claims abstract description 18
- 239000007788 liquid Substances 0.000 claims description 40
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 27
- 210000000130 stem cell Anatomy 0.000 claims description 22
- 230000009816 chondrogenic differentiation Effects 0.000 claims description 19
- 235000015097 nutrients Nutrition 0.000 claims description 19
- 102000043299 Parathyroid hormone-related Human genes 0.000 claims description 10
- 101710123753 Parathyroid hormone-related protein Proteins 0.000 claims description 10
- 238000011081 inoculation Methods 0.000 claims description 6
- 244000309466 calf Species 0.000 claims description 5
- 239000012530 fluid Substances 0.000 claims description 5
- 239000002609 medium Substances 0.000 claims description 5
- 210000002966 serum Anatomy 0.000 claims description 5
- 239000002054 inoculum Substances 0.000 claims description 4
- 239000004615 ingredient Substances 0.000 claims 1
- 210000004027 cell Anatomy 0.000 abstract description 71
- 230000006698 induction Effects 0.000 abstract description 35
- 229920002683 Glycosaminoglycan Polymers 0.000 abstract description 15
- 230000035755 proliferation Effects 0.000 abstract description 11
- 238000004113 cell culture Methods 0.000 abstract description 6
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 abstract description 5
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 abstract description 5
- 210000002744 extracellular matrix Anatomy 0.000 abstract description 5
- 238000001727 in vivo Methods 0.000 abstract description 5
- 230000028327 secretion Effects 0.000 abstract description 4
- 239000001963 growth medium Substances 0.000 abstract description 3
- 238000003501 co-culture Methods 0.000 abstract description 2
- 102000008186 Collagen Human genes 0.000 abstract 1
- 108010035532 Collagen Proteins 0.000 abstract 1
- 229920001436 collagen Polymers 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 102000002734 Collagen Type VI Human genes 0.000 description 44
- 108010043741 Collagen Type VI Proteins 0.000 description 44
- 210000001519 tissue Anatomy 0.000 description 41
- 239000000243 solution Substances 0.000 description 34
- 238000000926 separation method Methods 0.000 description 12
- 210000003954 umbilical cord Anatomy 0.000 description 10
- 102000004142 Trypsin Human genes 0.000 description 8
- 108090000631 Trypsin Proteins 0.000 description 8
- 230000008859 change Effects 0.000 description 8
- 238000001514 detection method Methods 0.000 description 8
- 239000012588 trypsin Substances 0.000 description 8
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 7
- 238000012258 culturing Methods 0.000 description 7
- 102100032912 CD44 antigen Human genes 0.000 description 6
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 6
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 description 6
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 6
- 101000935043 Homo sapiens Integrin beta-1 Proteins 0.000 description 6
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 6
- 102100025304 Integrin beta-1 Human genes 0.000 description 6
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 6
- 210000000845 cartilage Anatomy 0.000 description 6
- 239000006285 cell suspension Substances 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 5
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 5
- 210000004748 cultured cell Anatomy 0.000 description 5
- 238000004043 dyeing Methods 0.000 description 5
- 238000010166 immunofluorescence Methods 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 5
- 102000029816 Collagenase Human genes 0.000 description 4
- 108060005980 Collagenase Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000003321 cartilage cell Anatomy 0.000 description 4
- 229960002424 collagenase Drugs 0.000 description 4
- 210000002808 connective tissue Anatomy 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 210000002249 digestive system Anatomy 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 239000003292 glue Substances 0.000 description 4
- 210000003677 hemocyte Anatomy 0.000 description 4
- 229940000351 hemocyte Drugs 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 239000012982 microporous membrane Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 210000001644 umbilical artery Anatomy 0.000 description 4
- 210000003606 umbilical vein Anatomy 0.000 description 4
- 238000011109 contamination Methods 0.000 description 3
- 238000004904 shortening Methods 0.000 description 3
- OZFAFGSSMRRTDW-UHFFFAOYSA-N (2,4-dichlorophenyl) benzenesulfonate Chemical compound ClC1=CC(Cl)=CC=C1OS(=O)(=O)C1=CC=CC=C1 OZFAFGSSMRRTDW-UHFFFAOYSA-N 0.000 description 2
- 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 2
- 108060001084 Luciferase Proteins 0.000 description 2
- 239000005089 Luciferase Substances 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 2
- 229960003957 dexamethasone Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- QTENRWWVYAAPBI-YCRXJPFRSA-N streptomycin sulfate Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O QTENRWWVYAAPBI-YCRXJPFRSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000003676 Glucocorticoid Receptors Human genes 0.000 description 1
- 108090000079 Glucocorticoid Receptors Proteins 0.000 description 1
- 101000801254 Homo sapiens Tumor necrosis factor receptor superfamily member 16 Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 102100033725 Tumor necrosis factor receptor superfamily member 16 Human genes 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 210000004504 adult stem cell Anatomy 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000002659 cell therapy Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 208000017568 chondrodysplasia Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 210000002409 epiglottis Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000004728 pyruvic acid derivatives Chemical class 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310081154.3A CN103146645B (zh) | 2013-03-14 | 2013-03-14 | 诱导间充质干细胞成为软骨细胞的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310081154.3A CN103146645B (zh) | 2013-03-14 | 2013-03-14 | 诱导间充质干细胞成为软骨细胞的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103146645A CN103146645A (zh) | 2013-06-12 |
CN103146645B true CN103146645B (zh) | 2015-04-15 |
Family
ID=48544967
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310081154.3A Active CN103146645B (zh) | 2013-03-14 | 2013-03-14 | 诱导间充质干细胞成为软骨细胞的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103146645B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105602891A (zh) * | 2016-03-22 | 2016-05-25 | 深圳市第二人民医院 | 一种透明软骨细胞及制备方法 |
CN107338218B (zh) * | 2017-07-28 | 2020-11-24 | 中国人民解放军总医院第一附属医院 | 一种诱导脂肪干细胞向软骨细胞分化的诱导分化培养基和方法 |
CN109022355B (zh) * | 2018-08-30 | 2020-12-08 | 丰泽康生物医药(深圳)有限公司 | 一种提高间充质干细胞向软骨细胞分化的培养方法 |
CN111514374A (zh) * | 2020-04-24 | 2020-08-11 | 南京鼓楼医院 | 一种基于共培养系统构建的组织工程软骨促进软骨修复的方法 |
CN112370573B (zh) * | 2020-11-04 | 2023-06-23 | 山东佰傲干细胞生物技术有限公司 | 一种软骨膜片及其制备方法 |
CN115845142A (zh) * | 2022-12-23 | 2023-03-28 | 武汉大学 | 快速修复颌骨缺损的软骨样微组织的制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1563364A (zh) * | 2004-04-09 | 2005-01-12 | 华东理工大学 | 三维立体培养和诱导骨髓间充质干细胞成软骨细胞的方法 |
CN101036805A (zh) * | 2006-03-15 | 2007-09-19 | 尹飞 | 构建组织工程软骨的混合细胞方法 |
CN102899287A (zh) * | 2012-10-24 | 2013-01-30 | 天津和泽干细胞科技有限公司 | 一种诱导间充质干细胞向软骨细胞分化的方法及其在骨关节炎中的应用 |
-
2013
- 2013-03-14 CN CN201310081154.3A patent/CN103146645B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1563364A (zh) * | 2004-04-09 | 2005-01-12 | 华东理工大学 | 三维立体培养和诱导骨髓间充质干细胞成软骨细胞的方法 |
CN101036805A (zh) * | 2006-03-15 | 2007-09-19 | 尹飞 | 构建组织工程软骨的混合细胞方法 |
CN102899287A (zh) * | 2012-10-24 | 2013-01-30 | 天津和泽干细胞科技有限公司 | 一种诱导间充质干细胞向软骨细胞分化的方法及其在骨关节炎中的应用 |
Non-Patent Citations (5)
Title |
---|
TGF-β3诱导骨髓间充质干细胞表达软骨细胞表型的实验研究;赵基栋 等;《实用临床医药杂志》;20050930;第9卷(第11期);45-48页 * |
人MSC软骨诱导方案是什么啊?;jifeng3074 等;《http://www.dxy.cn/bbs/topic/11522565》;20080408;1页 * |
甲状旁腺激素相关蛋白对人间充质干细胞成骨和成脂分化的影响;张凯 等;《中华医学会第七次全国中青年检验医学学术会议会议论文集》;20120505;第553页左栏第2-3段 * |
重组人甲状旁腺激素1-34促进小鼠间充质干细胞增殖及骨向分化;易玲娴 等;《第三军医大学学报》;20110215;第33卷(第3期);262-265页 * |
骨髓间充质干细胞与关节软骨细胞Transwell共培养诱导形成软骨;王万宗 等;《中国组织工程研究与临床康复》;20100917;第14卷(第38期);第7042页左栏第1段、右栏第2-4段 * |
Also Published As
Publication number | Publication date |
---|---|
CN103146645A (zh) | 2013-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103146645B (zh) | 诱导间充质干细胞成为软骨细胞的方法 | |
Akhtar et al. | Accelerated photoreceptor differentiation of hiPSC-derived retinal organoids by contact co-culture with retinal pigment epithelium | |
CN102618491B (zh) | 诱导脂肪间充质干细胞向胰岛样细胞分化的培养液及诱导方法和用途 | |
Teramura et al. | Induction of mesenchymal progenitor cells with chondrogenic property from mouse-induced pluripotent stem cells | |
Yang et al. | Coculture-driven mesenchymal stem cell-differentiated articular chondrocyte-like cells support neocartilage development | |
Lambrechts et al. | Large-scale progenitor cell expansion for multiple donors in a monitored hollow fibre bioreactor | |
He et al. | Rejuvenation of nucleus pulposus cells using extracellular matrix deposited by synovium-derived stem cells | |
US20020045260A1 (en) | Method of isolating mesenchymal stem cells | |
CN106520687B (zh) | 一种诱导多能干细胞向间充质干细胞分化的方法 | |
Montemurro et al. | Angiogenic and anti-inflammatory properties of mesenchymal stem cells from cord blood: soluble factors and extracellular vesicles for cell regeneration | |
RU2012121842A (ru) | Способ получения мезенхимальных стволовых клеток из плюрипотентных стволовых клеток человека и мезенхимальные стволовые клетки, полученные этим способом | |
Lu et al. | Isolation and characterization of adipose-derived mesenchymal stem cells (ADSCs) from cattle | |
Kouroupis et al. | Generation of stem cell-based bioartificial anterior cruciate ligament (ACL) grafts for effective ACL rupture repair | |
Xue et al. | Isolation, identification, and comparison of cartilage stem progenitor/cells from auricular cartilage and perichondrium | |
CN105039248B (zh) | 树鼩骨髓间充质干细胞培养系统 | |
He et al. | Generation of mesenchymal-like stem cells from urine in pediatric patients | |
Xue et al. | Isolation and identification of stem cells in different subtype of cartilage tissue | |
Shima et al. | Rapid growth and osteogenic differentiation of mesenchymal stem cells isolated from human bone marrow | |
CN104774808A (zh) | 将脐带间充质干细胞诱导分化成γ-氨基丁酸能神经元的方法 | |
Karaoz et al. | Isolation and characterization of stem cells from pancreatic islet: pluripotency, differentiation potential and ultrastructural characteristics | |
CN114107187A (zh) | 一种牙髓间充质干细胞培养基及应用其的方法 | |
KR101896803B1 (ko) | 인간 만능줄기세포로부터 중간엽 줄기세포로의 분화 유도 생산율을 증가시키는 방법 및 이에 의해 생성된 중간엽 줄기세포 | |
Kang et al. | Chondrogenic differentiation of human adipose‑derived stem cells using microcarrier and bioreactor combination technique | |
Kim et al. | Directed differentiation of human mesenchymal stem cells toward a cardiomyogenic fate commitment through formation of cell aggregates | |
CN105886462A (zh) | 用于ADSCs培养的组合物及ADSCs培养方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PP01 | Preservation of patent right |
Effective date of registration: 20151110 Granted publication date: 20150415 |
|
RINS | Preservation of patent right or utility model and its discharge | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20161110 Granted publication date: 20150415 |
|
RINS | Preservation of patent right or utility model and its discharge | ||
PP01 | Preservation of patent right |
Effective date of registration: 20161110 Granted publication date: 20150415 |
|
RINS | Preservation of patent right or utility model and its discharge | ||
PD01 | Discharge of preservation of patent | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20191110 Granted publication date: 20150415 |
|
PP01 | Preservation of patent right | ||
PP01 | Preservation of patent right |
Effective date of registration: 20191110 Granted publication date: 20150415 |
|
PD01 | Discharge of preservation of patent | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20200827 Granted publication date: 20150415 |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200928 Address after: 518110 floors 1, 4, 5 and 6, No. 3, No. 8, Huarong Road, Tongsheng community, Dalang street, Longhua District, Shenzhen City, Guangdong Province Patentee after: GUANGDONG GOPOD GROUP Co.,Ltd. Address before: 518057, Shenzhen science and Technology Park, Guangdong, Nanshan District central science and technology, Malata Road, building 20 Patentee before: Shenzhen Potenbio Medical Technology Development Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201217 Address after: 528322 unit 502, block 3, plot 28-2, Fu'an Industrial Zone, Chonghe village, Leliu street, Shunde District, Foshan City, Guangdong Province Patentee after: Yizheng (Foshan) Medical Technology Co., Ltd Address before: 518110 1 / F, 1 / F, 4 / F, 5 / F, 6 / F, LianJian science and Technology Industrial Park, Huarong Road, Tongsheng community, Dalang street, Longhua District, Shenzhen City, Guangdong Province Patentee before: GUANGDONG GOPOD GROUP Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210426 Address after: 510030 room k1878, 16 / F, Xingguang Yingjing, 117 Shuiyin Road, Yuexiu District, Guangzhou City, Guangdong Province Patentee after: Guangdong Medical Co.,Ltd. Address before: No. 522, No. 522, Fude industrial district, No. 522, Shunliu village, Foshan City, Guangdong Province Patentee before: Yizheng (Foshan) Medical Technology Co., Ltd |